Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 575 (LINC00575) is a human long intergenic non-coding RNA gene, meaning it encodes a transcript longer than 200 nucleotides that does not overlap annotated protein-coding loci[1][3]. It is sometimes annotated with the alias C4orf11 and is classed as a lincRNA, a subclass of long non-coding RNAs that often function in regulation of gene expression, chromatin structure, and genome organization[5]. LINC00575 has not been experimentally confirmed to encode a protein or peptide and is generally not considered a traditional therapeutic target such as a receptor, enzyme, transporter, or transcription factor[1][3]. Its precise biological role, disease associations, and potential as a biomarker or drug target are not well established in the current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 575 (LINC00575).